| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.86T | 2.94T | 3.01T | 3.24T | 2.61T |
| Gross Profit | 618.35B | 662.76B | 710.43B | 788.05B | 613.06B |
| EBITDA | 477.52B | 491.82B | 484.59B | 446.98B | 379.25B |
| Net Income | 157.30B | 164.68B | 161.14B | 148.74B | 92.16B |
Balance Sheet | |||||
| Total Assets | 2.83T | 2.75T | 2.75T | 2.67T | 2.50T |
| Cash, Cash Equivalents and Short-Term Investments | 245.08B | 219.06B | 277.28B | 233.30B | 167.51B |
| Total Debt | 314.32B | 355.47B | 413.19B | 464.51B | 470.30B |
| Total Liabilities | 1.03T | 1.04T | 1.12T | 1.14T | 1.09T |
| Stockholders Equity | 1.59T | 1.52T | 1.45T | 1.37T | 1.26T |
Cash Flow | |||||
| Free Cash Flow | 119.72B | 103.88B | 174.08B | 148.53B | 75.91B |
| Operating Cash Flow | 412.51B | 406.53B | 456.60B | 393.77B | 341.47B |
| Investing Cash Flow | -265.70B | -307.35B | -255.79B | -232.97B | -213.03B |
| Financing Cash Flow | -111.33B | -178.88B | -146.57B | -113.71B | -107.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$2.50T | 8.75 | 10.04% | 6.32% | -6.92% | -2.57% | |
74 Outperform | HK$1.12T | 13.10 | 12.82% | 8.97% | -13.87% | -15.41% | |
68 Neutral | HK$1.33T | 7.65 | 16.65% | 6.76% | -9.81% | -8.84% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
62 Neutral | HK$239.36B | 8.39 | 10.99% | 4.59% | -3.42% | -18.73% | |
50 Neutral | HK$756.37B | 16.07 | ― | 5.52% | -10.02% | -27.89% |